Medicine and Dentistry
Dasatinib
100%
Drug Sensitivity
100%
Malignant Neoplasm
50%
Non Small Cell Lung Cancer
50%
Phosphotransferase Inhibitor
50%
Drug Action
50%
Lung Cancer Cell Line
50%
Neoplasm
25%
Gene Expression
25%
Anticarcinogen
25%
Genomic Instability
25%
Cell Signaling Pathway
25%
Cyclic AMP Dependent Protein Kinase
25%
Target Protein
25%
Drug Response
25%
Biochemistry, Genetics and Molecular Biology
Drug Sensitivity
100%
Dasatinib
100%
Cancer Cell
50%
Drug Mechanism
50%
Anticancer
25%
Gene Expression
25%
Genomics
25%
Genome Instability
25%
Phosphotransferase
25%
Kinase
25%
Protein Kinase A
25%
Drug Response
25%
Pharmacology, Toxicology and Pharmaceutical Science
Dasatinib
100%
Malignant Neoplasm
50%
Non Small Cell Lung Cancer
50%
Phosphotransferase Inhibitor
50%
Drug Action
50%
Neoplasm
25%
Lung Cancer
25%
Anticarcinogen
25%
Cyclic AMP Dependent Protein Kinase
25%
Keyphrases
Drug Sensitivity Prediction
100%
Personalized Medication
100%
Action Discovery
100%
Drug Mechanism of Action
28%
Response Heterogeneity
14%